At ESCMID Global 2025, Infectious Disease Frontier interviewed Dr. Francesco Cogliati Dezza to explore the renewed clinical relevance of temocillin. With resistance to broad-spectrum antibiotics on the rise, temocillin is gaining recognition as an effective carbapenem-sparing option, particularly against multidrug-resistant Enterobacterales. Dr. Cogliati Dezza highlighted temocillin’s role in antimicrobial stewardship and underscored the importance of re-evaluating older antibiotics in addressing the global challenge of AMR.
